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Chapter 4 
Tritylamine as an ammonia surrogate in the Ugi 
tetrazole synthesis  
Abstract 
The role of tritylamine is introduced as a convenient ammonia substitute in the Ugi tetrazole 
synthesis. Fifteen examples and their mild cleavage products are described in satisfactory to 
good yields. N-Unsubstituted α-aminotetrazoles are important compounds with annotated 
biological activities, and the described two-step synthesis provided an alternative route to 








Part of this thesis was published in: Org. Lett., 2013, 15, 3, 639–641. 
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4.1 Introduction 
The Ugi reaction is well-known for its very broad scope of different starting materials.1 
Thousands of reported examples revealed that most primary or secondary amines, aldehydes, 
ketones, and isocyanides could react with a suitable acid component.2-15 However, ammonia is 
one of the very few amine components which gives regularly unsatisfactory results in Ugi-type 
multicomponent reactions for many potential reasons. First, ammonia is a very reactive amine, 
and the Schiff bases of ammonia are known to be unstable and to rapidly cyclo-trimerize or 
oligomerize. The Schiff base is a key intermediate in all Ugi-type multicomponent reactions 
(MCRs).16-19 The slow kinetic reversibility of the Schiff base oligomer monomer equilibrium 
could hinder the progress of the Ugi MCR and also potentially lead to side reactions. The high 
basicity of ammonia used in excess could suppress Lewis and Brønsted acid mediated activation 
of the intermediate Schiff base. In the tetrazole and Ugi-3CR variation the Schiff base causes a 
primary amine to be formed from use of ammonia. This primary amine, however, is very 
reactive and can undergo an additional Ugi reaction; with highly reactive oxo components, e.g., 
formaldehyde, even a third Ugi reaction can even lead to a mixture of multiple products. In fact, 
the HPLC-MS analysis of the reaction of tert-butyl isocyanide with formaldehyde, ammonia, 
and TMS-azide revealed such a mixture of mono-, di-, and tri Ugi products. While several 
ammonia substitutes such as ammonium formiate,20 ferrocenylalkylamines,21 substituted 
benzylamines,22 and anomeric glycosylamines23 have been described in the past for the Ugi-
4CR, no conveniently and mildly cleavable substitutes were known for the Ugi tetrazole 
synthesis.24, 25 N-Unsubstituted α-aminotetrazoles, however, are potentially biologically active 
compounds with currently no described synthetic pathway. Therefore, we report our results 
introducing tritylamine as a convenient ammonia surrogate in the Ugi tetrazole synthesis 
(Scheme 4.1). 
 
Scheme 4.1. Design of a synthetic pathway to N-unsubstituted primary α-amino tetrazole 
using a Ugi-4CR employing tritylamine as an ammonia surrogate. 
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4.2 Results and discussion 
At the beginning of our investigations, it was not clear that tritylamine, although a well-
known amine protecting group often used in peptide chemistry, might work well in the crucial 
Schiff base formation due to sterical hindrance. We were pleased to find the expected product 
during the room temperature reaction of cyclohexylisocyanide, isobutyraldehyde, tritylamine, 
and TMS-azide in methanol, however, accompanied with mostly starting materials indicated 
the low conversion. Switching to microwave conditions (100 oC, 30 min, and ethanol) has led 
to good conversion and isolation of the Ugi product in satisfactory yields (1i, 70%). In order to 
find out the rate-limiting step (Schiff base formation or R-addition and subsequent tetrazole 
formation), we attempted to run both reactions at room temperature. It was found that the Schiff 
base formation was too slow at room temperature but successful if performed under microwave 
conditions. Interestingly, we found when we mixed the isolated Schiff base with the isocyanide 
and TMSN3 (ethanol, 24 h) the reaction yielded N-trityl-protected α-aminotetrazoles (1d, 55%) 
in even slightly higher yields than that of microwave condition (1d, 47%). It was concluded 
that the microwave or thermal conditions must be employed for the Schiff base formation of 
tritylamine but not for the subsequent Ugi reaction. For the sake of a convenient procedure, 
however, all subsequent reactions were performed in the microwave in a one-pot fashion. In 
order to test the scope and limitations of the reaction, several isocyanides and aldehydes were 
tested (Scheme 4.1and Table 4.1). Cyclohexanone, which previously has been described in the 
literature as a good substrate for diverse Ugi reactions, was reacted; however, the expected 
product could not be isolated. This is presumably due to the high sterical hindrance of the two 
reactants, and not surprisingly, no such Schiff base with tritylamine has been reported with a 
ketone via a condensation reaction. 
The deprotection of the Ugi intermediates could be performed under standard conditions 
(DCM, TFA, r.t., 1 min). The products were isolated by chromatography in near quantitative 
yields (Table 4.1).  
It was widely accepted that the mechanism of the Ugi reaction involves first Schiff base 
formation (or enamine in the case of secondary amines), followed by an activation step of the 
imine by a Lewis or Brønsted acid. Addition of the isocyanide via the carbon onto the Schiff 
base yields an intermediate nitrilium ion, addition of the acid, and a final irreversible 
sigmatropic rearrangement to the product, a tetrazole in the present case (Scheme 4.2).  
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This mechanistic proposal has been recently also supported by theoretically high-level 
molecular orbital calculations.26 
 
Scheme 4.2. Ugi Tetrazole mechanism 
Table 4.1. Yields of N-trityl protected α-aminotetrazoles (1) and N-deprotected α-
aminotetrazoles (2) 
No. R1 R2 Yield 1 (%)  Yield 2 (%) 
a H2 C6H5(CH2)2 83 99
b CH3 C6H5(CH2)2 80 99
c (CH3)2CH C6H5(CH2)2 76 99
d CH3S(CH2)2 C6H5CH2 47 99
e (CH3)2CHCH2 C6H5CH2 87 86
f cyclopropionyl C6H5CH2 73 99
g CH3 cyclohexyl 81 98
h isopentyl C6H5CH2 66 99
i (CH3)2CH cyclohexyl 70 99
g C6H5CH2 cyclohexyl 41 99
k cyclohexyl cyclohexyl 87 99
l C6H5(CH2)2 cyclohexyl 75 99
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m CH3OCO(CH2)2 C6H5(CH2)2 65 99
n CH3CH2OCOC3H4 C6H5(CH2)2 77 99
o CH3CH2OCOC3H4 (CH3)3 46 98
The present Ugi reaction was, however, surprising in several respects. First, the reactive imine 
carbon next to the tritylamine unit is sterically very hindered and reacts with the bulky 
isocyanide to give the nitrilium species. Then the azide anion has to add onto this species to 
yield the α-adduct. To underscore the bulkiness of this intermediate a molecular modeling 
picture of the presumed intermediate of product 2k is depicted in Figure 4.1.26 After the ring 
closure, the α-amino tetrazole is formed. The compounds generally crystallized well, and two 
typical highly crowded examples are shown in Figure 4.2 in the solid state. After trityl 
deprotection, the primary amines are obtained as TFA salts which also nicely crystallized 
(Figure 4.2). 
 
Figure 4.1. Spheres model of the α-adduct during the formation of tetrazole 2k illustrating 
the crowdedness of the reaction intermediate. 
4.3 Conclusions 
N-Tetrazole-substituted and amino-N-unsubstituted α-amino tetrazoles so far have been only 
synthesized via the Ugi reaction.25 We have now introduced tritylamine as a convenient and 
easily cleavable ammonia surrogate that reacts together with aldehydes, TMS-azide, and 
isocyanides to yield N-trityl α-aminotetrazoles. The N-unsubstituted α-aminotetrazoles were 
obtained under very mild and standard trityl deprotecting conditions. Despite steric hindrance, 
the Ugi reaction proceeded smoothly and the products could be isolated in good to satisfactory 
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yields. Work is ongoing to investigate the further synthetic applications and biological 
properties of the new compounds. 
 
 
Figure 4.2. Molecular structure of 1b, 1c in the solid state illustrating the crowdedness of the 
trityl protected products. Molecular structure of trityl cleaved products 2k and 2l in the solid 
state. ORTEP ellipsoids drawn at the 50% probability level. 
4.4 Experimental section 
4.4.1 General methods 
Nuclear magnetic resonance spectra were recorded on a Bruker Avance 500 spectrometer (1H 
NMR (500 MHz), 13C NMR (125 MHz)) or a Varian Inova 400 MHz spectrometer (1H NMR 
(400 MHz), 13C NMR (100 MHz)). Chemical shifts for 1H NMR were reported as δ values and 
coupling constants were in hertz (Hz). The following abbreviations were used for spin 
multiplicity: s = singlet, d = doublet, t = triplet, dd = double doublet, m = multiplet. Chemical 
shifts for 13C NMR reported in ppm relative to the solvent peak. Mass spectra were measured 
on an API 3000 triple-quadrupole mass spectrometer (Applied Biosystems/MDS Sciex) via a 
TurboIonSpray source. Data collected and analyzed by the Analyst 1.5 data acquisition software 
(Applied Biosystems/MDS Sciex). The mass for N-deprotected α-aminotetrazoles were denoted 
without the trifluoroacetate. Filtrations were performed on a silica bed (Ecochrom MP 32-63, 
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60 A). All the irradiations were performed on a microwave initiator from Biotage. Thin layer 
chromatography was performed on Fluka precoated silica gel plates (0.20 mm thick, particle 
size 25 μm). Flash chromatography was performed on a Teledyne ISCO Combiflash Rf, using 
RediSep Rf Normal-phase Silica Flash Columns (Silica Gel 60 A, 230 - 400 mesh). Reagents 
were available from commercial suppliers and used without any purification unless otherwise 
noted. Ethyl 2-formyl-1-cyclopropanecarboxylate was offered from Aldrich, the product 
number is 157279, 96%, predominantly trans. 
4.4.2 Synthesis and characterization of N-trityl protected α-aminotetrazoles 
General procedure for the synthesis of N-trityl protected α-aminotetrazoles 
Aldehyde (1.5 mmol) and tritylamine (1 mmol) were suspended in EtOH (1 mL) in a sealed 
vial with a magnetic stirring bar. The reaction was heated at 100oC for 15 minutes using 
microwave irradiation. Then isocyanide (1 mmol) and azidotrimethylsilane (1 mmol) were 
added into the reaction mixture and further heated at 100oC for 15 minutes using microwave 
irradiation. The solvent was removed under reduced pressure and the residue was purified using 
flash chromatography. 
N-((1-Phenethyl-1H-tetrazol-5-yl)methyl)-1,1,1-triphenylmethanamine (1a)  
The product was obtained as a light yellow solid (83%). Rf 0.49 (heptane : EtOAc 1:1); 1H 
NMR (500 MHz, CDCl3) δ 7.45 - 7.43 (m, 6H), 7.31 - 7.28 (m, 6H), 7.25 - 7.22 (m, 3H), 7.16 
- 7.15 (m, 3H), 6.84 - 6.82 (m, 2H), 4.38 (t, J = 6.8, 2H), 3.17 (s, 2H), 3.10 (t, J = 6.8, 2H), 2.32 
(s, 1H) ppm; 13C (125 MHz, CDCl3) δ 154.3, 144.8, 136.5, 129.2, 128.8, 128.3, 127.6, 127.1, 
71.4, 48.9, 36.8, 36.5 ppm; MS (ESI) m/z calculated [M+H]+: 446.2; found [M+H]+: 446.2. 
1-(1-Phenethyl-1H-tetrazol-5-yl)-N-tritylethanamine (1b)  
The product was obtained as a light yellow solid (80%). Rf 0.42 (heptane : EtOAc 1:1); 1H 
NMR (500 MHz, CDCl3) δ 7.40 - 7.38 (m, 6H), 7.26 - 7.21 (m, 9H), 7.19 - 7.16 (m, 3H), 6.96 
- 6.95 (m, 2H), 4.08 - 4.03 (m, 1H), 3.77 - 3.67 (m, 2H), 3.07 - 2.98 (m, 3H), 1.00 (d, J = 6.9, 
3H) ppm; 13C (125 MHz, CDCl3) δ 159.1, 145.5, 136.8, 129.1, 128.9, 128.8, 128.1, 127.5, 
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2-Methyl-1-(1-phenethyl-1H-tetrazol-5-yl)-N-tritylpropan-1-amine (1c)  
The product was obtained as a light yellow solid (76%). Rf 0.41 (heptane : EtOAc 1:1); 1H 
NMR (500 MHz, CDCl3) δ 7.46 - 7.44 (m, 6H), 7.38 - 7.35 (m, 3H), 7.33 - 7.31, 7.26 (m, 2H) 
- 7.21 (m, 6H), 7.20 - 7.17 (m, 3H), 3.83 - 3.80 (m, 3H), 3.14 - 3.09 (m, 3H), 2.22 - 2.14 (m, 
1H), 1.04 (d, J = 6.7, 3H), 0.74 (d, J = 6.9, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ 156.0, 
145.4, 136.8, 129.0, 128.8, 128.7, 127.9, 127.4, 126.8, 71.4, 52.9, 48.7, 35.1, 35.0, 19.4, 17.7 
ppm; MS (ESI) m/z calculated [M+H]+: 488.3; found [M+H]+: 488.3. 
1-(1-Benzyl-1H-tetrazol-5-yl)-3-(methylthio)-N-tritylpropan1-amine (1d)  
The product was obtained as a light yellow solid (47%). Rf 0.45 (heptane : EtOAc 1:1) ; 1H 
NMR (500 MHz, CDCl3) δ 7.37 - 7.36 (m, 6H), 7.29 - 7.27 (m, 3H), 7.23 - 7.15 (m, 9H), 7.03 
- 7.02 (m, 2H), 5.21 (d, J = 15.4, 1H), 4.65 (d, J = 15.4, 1H), 4.11 - 4.07 (m, 1H), 2.98 (d, J = 
9.0, 1H), 2.30 - 2.25 (m, 1H), 2.04 - 1.96 (m, 1H), 1.86 - 1.74 (m, 4H), 1.64 - 1.60 (m, 3H) 
ppm; 13C NMR (125 MHz, CDCl3) δ 157.5, 145.4, 133.6, 129.3, 129.1, 128.7, 128.2, 127.9, 
127.0, 71.7, 51.0, 47.5, 36.6, 29.5, 15.5 ppm; MS (ESI) m/z calculated [M+H]+: 506.2; found 
[M+H]+: 506.4. 
3-Methyl-1-(1-phenethyl-1H-tetrazol-5-yl)-N-tritylbutan-1-amine (1e)  
The product was obtained as a light yellow solid (87%). Rf  0.39 (heptane : EtOAc 2:1); 1H 
NMR (500 MHz, CDCl3) δ 7.37 - 7.36 (m, 6H), 7.29 - 7.28 (m, 3H), 7.23 - 7.20 (m, 6H), 7.19 
- 7.16 (m, 3H), 7.06 - 7.04 (m, 2H), 5.49 (d, J = 15.5, 1H), 4.97 (d, J = 15.5, 1H), 4.14 - 4.10 
(m, 1H), 2.62 (d, J = 6.3, 1H), 1.27 - 1.20 (m, 2H), 1.03 - 0.99 (m, 1H), 0.53 (d, J = 6.5, 3H), 
0.46 (d, J = 6.6, 3H) ppm; 13C (100 MHz, CDCl3) δ 157.6, 145.1, 134.0, 129.0, 128.6, 128.6, 
128.0, 127.3, 126.9, 71.7, 50.8, 47.1, 46.3, 24.1, 22.8, 22.0 ppm; MS (ESI) m/z calculated 
[M+H]+: 488.3; found [M+H]+: 488.3. 
N-((1-Benzyl-1H-tetrazol-5-yl)(cyclopropyl)methyl)-1,1,1-triphenylmethanamine (1f)  
The product was obtained as a light yellow solid (73%). Rf  0.35 (heptane : EtOAc 2:1); 1H 
NMR (500 MHz, CDCl3) δ 7.39 - 7.37 (m, 6H), 7.29 - 7.28 (m, 3H), 7.23 - 7.15 (m, 9H), 7.08 
- 7.07 (m, 2H), 5.47 (d, J = 15.4, 1H), 4.80 (d, J = 15.4, 1H), 3.72 (dd, J = 7.6, 5.2, 1H), 2.94 
(d, J = 5.3, 1H), 0.85 - 0.81 (m, 1H), 0.29 - 0.10 (m, 3H), -0.30 - -0.34 (m, 1H) ppm; 13C (125 
MHz, CDCl3) δ 156.7, 144.8, 134.0, 128.8, 128.5, 128.5, 127.8, 127.5, 126.7, 71.3, 51.2, 50.6, 
17.1, 4.2, 2.2 ppm; MS (ESI) m/z calculated [M+H]+: 472.3; found [M+H]+: 472.3. 
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1-(1-Cyclohexyl-1H-tetrazol-5-yl)-N-tritylethanamine (1g)  
The product was obtained as a white solid (81%). Rf 0.42 (heptane : EtOAc 1:1); 1H NMR 
(500 MHz, CDCl3) δ 7.43 - 7.41 (m, 6H), 7.22 - 7.19 (m, 6H), 7.17 - 7.14 (m, 3H), 4.01 - 3.95 
(m, 1H), 3.69 - 3.66 (m, 1H), 3.09 (d, J = 8.2, 1H), 1.93 - 1.89 (m, 2H), 1.69 - 1.62 (m, 4H), 
1.38 (d , J = 6.9, 3H), 1.31 - 1.22 (m, 4H) ppm; 13C (100 MHz, CDCl3) δ 157.5, 144.9, 128.1, 
127.3, 126.2, 71.2, 56.7, 43.9, 33.0, 31.2, 24.6, 24.6, 24.2, 24.0 ppm; MS (ESI) m/z calculated 
[M+H]+: 438.3; found [M+H]+: 438.3. 
1-(1-Benzyl-1H-tetrazol-5-yl)-2-methyl-N-tritylbutan-1-amine (1h)  
The product was obtained as a mixture of diastereomers as a light yellow solid (66%). Rf 0.52 
(heptane : EtOAc 1:1); 1H NMR (500 MHz, CDCl3) δ 7.40 - 7.38 (m, 6H), 7.27 - 7.26 (m, 3H), 
7.19 - 7.15 (m, 9H), 7.08 - 7.06 (m, 2H), 5.10 (dd, J = 22.9, 15.5, 1H), 4.65 (dd, J = 24.6, 15.5, 
1H), 4.01 - 3.90 (m, 1H), 2.97 - 2.92 (m, 1H), 1.74 - 1.70 (m, 1H), 1.69 - 1.62 (m, 2H), 1.48 - 
1.31 (m, 1H), 1.16 - 1.08 (m, 1H), 0.80 - 0.79 (m, 2H), 0.69 - 0.68 (m, 3H), 0.63 - 0.61 (m, 2H) 
ppm; 13C (100 MHz, CDCl3) δ 221.1, 156.6, 156.4, 145.2, 133.2, 133.1, 128.7, 128.6, 128.4, 
127.7, 127.7, 126.5, 71.9, 71.1, 70.8, 51.9, 50.6, 50.5, 41.6, 41.3, 25.7, 25.3, 14.4, 14.2, 12.0, 
11.6 ppm; MS (ESI) m/z calculated [M+H]+: 488.3; found [M+H]+:488.4. 
1-(1-Cyclohexyl-1H-tetrazol-5-yl)-2-methyl-N-tritylpropan-1-amine (1i)  
The product was obtained as a white solid (70%). Rf 0.45 (heptane : EtOAc 1:1); 1H NMR 
(500 MHz, CDCl3) δ 7.40 - 7.39 (m, 6H), 7.21 - 7.18 (m, 6H), 7.16 - 7.14 (m, 3H), 3.85 - 3.83 
(m, 2H), 2.82 (d, J = 6.6, 1H), 1.91 - 1.86 (m, 3H), 1.83 - 1.79 (m, 2H), 1.73 -1.71 (m, 2H), 
1.37 - 1.21 (m, 4H), 0.79 (d, J = 6.8, 3H), 0.65 (d, J = 6.8, 3H) ppm; 13C (100 MHz, CDCl3) δ 
156.1, 145.5, 128.9, 128.0, 126.9, 71.9, 57.8, 53.0, 34.6, 33.4, 32.5, 25.0, 19.1, 18.7 ppm MS 
(ESI) m/z calculated [M+H]+: 466.3; found [M+H]+: 466.2. 
1-(1-Cyclohexyl-1H-tetrazol-5-yl)-2-phenyl-N-tritylethanamine (1j)  
The product was obtained as a light yellow solid (41%). Rf  0.50 (heptane : EtOAc 1:1) 0.5; 
1H NMR (500 MHz, CDCl3) δ 7.46 - 7.45 (m, 6H), 7.25 - 7.23 (m, 6H), 7.19 - 7.18 (m, 3H), 
7.08 - 7.07 (m, 3H), 6.58 - 6.56 (m, 2H), 3.99 - 3.97 (m, 1H), 3.13 - 3.09 (m, 1H), 2.90 - 2.85 
(m, 2H), 2.51 - 2.47 (m, 1H), 1.66 - 1.59 (m, 5H), 1.28 - 1.23 (m, 3H), 0.89 - 0.81 (m, 2H) ppm; 
13C (100 MHz, CDCl3) δ 157.2, 157.1, 145.8, 136.7, 129.5, 129.0, 128.8, 128.2, 127.1, 72.3, 
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57.6, 51.1, 50.7, 44.4, 44.4, 32.4, 25.3, 25.3, 24.8 ppm; MS (ESI) m/z calculated [M+H]+: 
514.3; found [M+H]+:514.4. 
N-(Cyclohexyl(1-cyclohexyl-1H-tetrazol-5-yl)methyl)-1,1,1-triphenylmethanamine (1k)  
The product was obtained as a white solid (87%). Rf 0.49 (heptane : EtOAc 1:1); 1H NMR 
(500 MHz, CDCl3) δ 7.40 - 7.38 (m, 6H), 7.22 - 7.19 (m, 6H), 7.17 - 7.14 (m, 3H), 3.91 - 3.83 
(m, 2H), 1.90 - 1.79 (m, 5H), 1.73 - 1.55 (m, 5H), 1.36 - 1.24 (m, 6H), 1.02 - 0.84 (m, 4H), 0.44 
- 0.39 (m, 1H) ppm; 13C (125 MHz, CDCl3) δ 156.3, 145.7, 129.0, 128.0, 126.9, 72.0, 57.8, 
52.8, 44.3, 33.5, 32.6, 29.8, 28.9, 26.3, 26.3, 26.2, 25.7, 25.6, 25.0 ppm; MS (ESI) m/z 
calculated [M+H]+: 506.3; found [M+H]+: 506.4. 
1-(1-Cyclohexyl-1H-tetrazol-5-yl)-3-phenyl-N-tritylpropan-1-amine (1l)  
The product was obtained as a white solid (75%). Rf 0.51 (heptane : EtOAc 1:1); 1H NMR 
(500 MHz, CDCl3) δ 7.44 - 7.43 (m, 6H), 7.24 - 7.21 (m, 9H), 7.19 - 7.16 (m, 3H), 6.98 - 
6.96(m, 2H), 4.12 - 4.08 (m, 1H), 3.77 - 3.74 (m, 1H), 2.95 (d, J = 7.2, 1H), 2.60 - 2.54 (m, 
1H), 2.37 - 2.31 (m, 1H), 2.19 - 2.13 (m, 1H), 1.93 - 1.62 (m, 9H), 1.25 - 1.24 (m, 2H) ppm; 
13C (125 MHz, CDCl3) δ 156.1, 145.3, 140.7, 128.6, 128.4, 128.1, 127.9, 126.7, 126.0, 71.9, 
57.4, 38.6, 30.9, 25.2, 24.7 ppm; MS (ESI) m/z calculated [M+H]+: 528.3; found [M+H]+: 
528.5. 
Methyl 4-(1-phenethyl-1H-tetrazol-5-yl)-4-(tritylamino)butanoate (1m)  
The product was obtained as a white solid (65%). Rf 0.32 (heptane : EtOAc 1:1); 1H NMR 
(400 MHz, CDCl3) δ 7.37 - 7.36 (m, 6H), 7.23 - 7.20 (m, 2H), 7.19 - 7.15 (m, 7H), 7.14 - 7.12 
(m, 3H), 7.01 (m, 2H), 3.99 - 3.90 (m, 2H), 3.76 (m, 1H), 3.65 (s, 3H), 3.12 - 2.99 (m, 3H), 
2.52 - 2.46 (m, 1H), 2.13 - 2.09 (m, 1H), 1.94 - 1.87 (m, 1H), 1.28 - 1.25 (m, 1H) ppm; 13C (100 
MHz, CDCl3) δ 173.4, 157.2, 145.2, 136.7, 128.9, 128.8, 128.7, 128.0, 127.7, 127.4, 126.9, 
71.6, 51.9, 50.2, 48.6, 47.0, 36.4, 35.5, 31.8, 29.0 ppm; MS (ESI) m/z calculated [M+H]+: 
532.3; found [M+H]+: 532.4. 
Ethyl 2-((1-phenethyl-1H-tetrazol-5-yl)(tritylamino)methyl)cyclopropanecarboxylate 
(1n)  
The product was obtained as a mixture of diastereomers as a light yellow solid (77%). Rf 0.47 
(heptane : EtOAc 1:1); 1H NMR (400 MHz, CDCl3) δ 7.39 - 7.31 (m, 8H), 7.27 - 7.24 (m, 1H), 
7.21 - 7.14 (m, 9H), 7.11 - 7.09 (m, 2H), 4.14 - 4.08 (m, 2H), 4.01 - 3.79 (m, 1H), 3.11 - 2.99 
Tritylamine as an ammonia surrogate 
Page | 197 
(m, 2H), 1.61 - 1.55 (m, 3H), 1.26 - 1.13 (m, 4H), 1.06 - 0.93 (m, 1H), 0.90 - 0.87 (m, 1H) ppm; 
13C (100 MHz, CDCl3) δ 173.2, 173.0, 156.0, 156.0, 145.1, 144.9, 136.5, 128.2, 128.2, 128.0, 
127.6, 127.6, 127.2, 127.1, 126.6, 71.7, 61.0, 48.9, 48.7, 35.6, 35.5, 32.1, 27.0, 19.6, 17.8, 14.4, 
12.4 ppm; MS (ESI) m/z calculated [M+H]+: 558.3; found [M+H]+: 558.2. 
Ethyl 2-((1-(tert-butyl)-1H-tetrazol-5-yl)(tritylamino)methyl)cyclopropanecarboxylate 
(1o)  
The product was obtained as a mixture of diastereomers as a white solid (46%). Rf  0.47 
(heptane : EtOAc 1:1); 1H NMR (400 MHz, CDCl3) δ 7.37 - 7.35 (m, 6H), 7.17 - 7.11 (m, 6H), 
7.11 - 7.09 (m, 3H), 4.13 - 4.07 (m, 1H), 3.98 - 3.90 (m, 1H), 1.38 (s, 9H), 1.25 - 1.21 (m, 2H), 
1.11 -1.07 (t, J = 7.1, 1H), 1.09 - 0.95 (m, 1H), 0.94 - 0.82 (t, J = 6.8, 1H) ppm; 13C (100 MHz, 
CDCl3) δ 173.4, 155.5, 145.6, 128.8, 127.8, 126.8, 71.7, 61.8, 60.6, 60.4, 31.9, 30.1, 27.4, 22.7, 
14.2 ppm; MS (ESI) m/z calculated [M+H]+: 510.3; found [M+H]+: 510.4. 
4.4.3 Synthesis and characterization of N-deprotected α-aminotetrazoles 
General procedure for the deprotection of N-trityl protected α-aminotetrazoles 
N-trityl protected α-aminotetrazole (0.5 mmol) was dissolved in dicloromethane (2.5 mL) in 
a vial with a magnetic stirring bar. Trifluoroacetic acid (1 mmol, 77 μL) was added dropwise. 
The reaction developed for 1min. The reaction mixture was purified using a silica bed wetted 
with Heptane : EtOAc (1:1). The side product was washed out with heptane ：EtOAc (1:1). 
The N-deprotected α-aminotetrazole was collected with methanol: CH2Cl2 (1:1). The solvent 
was removed under reduced pressure which gave the pure product. 
(1-Phenethyl-1H-tetrazol-5-yl)methanamine 2,2,2-trifluoroacetate (2a)  
The product was obtained as a light yellow solid (99%). Rf 0.59 (CH2Cl2 : MeOH 9:1) ; 1H 
NMR (400 MHz, Methanol-d4) δ 6.83 - 6.77 (m, 3H), 6.58 -6.55 (m, 2H), 4.17 (t, J = 6.7, 2H), 
2.81 (m, 3H), 2,72 (t, J =6.7, 2H) ppm; 13C (100 MHz, Methanol- d4) δ 151.7, 138.2, 130.1, 
130.0, 128.5, 50.3, 36.8, 33.5 ppm; MS (ESI) m/z calculated [M+H]+: 204.1; found [M+H]+: 
204.1. 
1-(1-Phenethyl-1H-tetrazol-5-yl)ethanamine 2,2,2-trifluoroacetate (2b)  
The product was obtained as a light yellow solid (99%). Rf 0.67 (CH2Cl2 : MeOH 9:1); 1H 
NMR (400 MHz, Methanol- d4) δ 7.28 - 7.24 (m, 3H), 7.09 - 7.07 (m, 2H), 4.77 - 4.61 (m, 2H), 
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4.44 - 4.39 (m, 1H), 3.30 - 3.27 (m, 2H), 1.21 (d, J = 6.8, 3H) ppm; 13C (100 Hz, Methanol- d4) 
δ 155.8, 142.8, 138.2, 130.0, 128.4, 50.2, 41.8, 36.4, 19.0 ppm; MS (ESI) m/z calculated 
[M+H]+: 218.1; found [M+H]+: 218.1. 
2-Methyl-1-(1-phenethyl-1H-tetrazol-5-yl)propan-1-amine 2,2,2-trifluoroacetate (2c)  
The product was obtained as a white solid (99%). Rf 0.43 (SiO2, CH2Cl2 : MeOH 9:1); 1H 
NMR (400 MHz, Methanol- d4) δ 7.31 - 7.24 (m, 3H), 7.19 - 7.18 (m, 2H), 4.68 (t, J = 7.0, 2H), 
4.44 (d, J = 6.8, 1H), 3.41 - 3.32 (m, 2H), 2.02 - 1.93 (m,1H), 0.92 (d, J = 6.8, 3H), 0.79 (d, J 
= 6.9, 3H) ppm; 13C (100 Hz, Methanol- d4) δ 153.9, 138.2, 130.1, 130.0, 128.3, 50.9, 50.3, 
36.4, 32.8, 18.6, 17.7 ppm; MS (ESI) m/z calculated [M+H]+: 246.2; found [M+H]+: 246.1. 
1-(1-Benzyl-1H-tetrazol-5-yl)-3-(methylthio)propan-1-amine 2,2,2-trifluoroacetate (2d)  
The product was obtained as a light yellow solid (99%). Rf  0.52 (CH2Cl2 : MeOH 9:1) ; 1H 
NMR (400 MHz, Methanol- d4) δ 7.45 - 7.42 (m, 3H), 7.39 - 7.37 (m, 2H), 5.85 (d, J = 15.6, 
1H), 5.74 (d, J = 15.6, 1H), 4.93 - 4.91 (m, 2H), 2.43 - 2.36 (m, 1H), 2.31 - 2.24 (m, 1H), 2.19 
- 2.13 (m, 2H), 1.93 (s, 3H) ppm; 13C NMR (100 MHz, Methanol- d4) δ 156.8, 134.9, 130.4, 
130.2, 129.1, 52.1, 45.1, 33.6, 29.8, 15.0 ppm; MS (ESI) m/z calculated [M+H]+: 264.1; found 
[M+H]+: 264.1. 
1-(1-Benzyl-1H-tetrazol-5-yl)-3-methylbutan-1-amine 2,2,2-trifluoroacetate (2e)  
The product was obtained as a white solid (86%). Rf 0.60 (CH2Cl2 : MeOH 9:1); 1H NMR 
(400 MHz, Methanol- d4) δ 7.43 - 7.41 (m, 3H), 7.31 - 7.29 (m, 2H), 5.89 (d, J = 15.7, 1H), 
5.68 (d, J = 15.7, 1H), 4.76 - 4.72 (m, 1H), 1.81 - 1.74 (m, 1H), 1.57 (m, 1H), 1.45 - 1.35 (m, 
1H), 0.78 (d, J = 6.5, 3H), 0.70 (d, J = 6.5, 3H) ppm; 13C NMR (100 MHz, Methanol- d4) δ 
154.7, 135.0, 130.4, 130.2, 128.9, 52.0, 44.3, 42.9, 25.3, 22.7, 22.0 ppm; MS (ESI) m/z 
calculated [M+H]+: 246.1; found [M+H]+: 246.1. 
(1-Benzyl-1H-tetrazol-5-yl)(cyclopropyl)methanamine 2,2,2-trifluoroacetate (2f)  
The product was obtained as a white solid (99%). Rf  0.56 (CH2Cl2 : MeOH 9:1); 1H NMR 
(500 MHz, Methanol- d4) δ 7.44 - 7.40 (m, 3H), 7.30 - 7.29 (m, 2H), 5.84 (d, J = 15.7, 1H), 
5.69 (d, J = 15.7, 1H), 4.41 - 4.39 (m, 1H), 3.33 (s, 1H), 1.44 - 1.38 (m, 1H), 0.78 - 0.72 (m, 
1H), 0.53 - 0.47 (m, 1H), 0.46 - 0.41 (m, 1H), 0.22 - 0.18 (m, 1H) ppm; 13C (100 MHz, 
Methanol- d4) δ 154.1, 135.5, 130.4, 130.2, 128.9, 52.1, 50.3, 14.8, 4.8, 4.3 ppm; MS (ESI) m/z 
calculated [M+H]+: 230.1; found [M+H]+: 230.1. 
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1-(1-Cyclohexyl-1H-tetrazol-5-yl)ethanamine 2,2,2-trifluoroacetate (2g)  
The product was obtained as a white solid (98%). Rf 0.69 (CH2Cl2 : MeOH 9:1); 1H NMR 
(400 MHz, Methanol- d4) δ 4.99 - 4.96 (m, 1H), 4.43 - 4.38 (m, 1H), 3.22 - 3.21 (m, 1H), 1.92 
- 1.83 (m, 6H), 1.70 - 1.67 (m, 1H), 1.60 (d, J = 6.8, 3H), 1.49 - 1.43 (m, 2H), 1.32 - 1.20 (m, 
1H) ppm; 13C NMR (100 MHz, Methanol- d4) δ 154.4, 59.4, 42.6, 34.5, 34.0, 26.2, 26.1, 19.6 
ppm; MS (ESI) m/z calculated [M+H]+: 196.2; found [M+H]+: 196.1. 
1-(1-Benzyl-1H-tetrazol-5-yl)-2-methylbutan-1-amine 2,2,2-trifluoroacetate (2h)  
The product was obtained as a white solid as a mixture of diastereomers (99%). Rf 0.65 
(CH2Cl2 : MeOH 9:1) 0.65; 1H NMR (400 MHz, Methanol- d4) δ 7.44 - 7.37 (m, 3H), 7.37 - 
7.33 (m, 2H), 5.84 (dd, J = 15.5, 3.6, 1H), 5.68 (d, J = 15.6, 1H), 4.66 (dd, J = 6.6, 3.5, 2H), 
1.51 - 1.45 (m, 1H), 1.23 - 1.02 (m, 2H), 0.92 (d, J = 6.9, 1H), 0.82 (t, J = 7.3, 3H), 0.74 (d, J 
= 6.9, 2H) ppm; 13C NMR (100 MHz, Methanol- d4) δ 152.6, 130.3, 130.2, 129.2, 129.1, 52.1, 
50.4, 39.3, 39.2, 26.6, 25.1, 14.8, 13.8, 11.7, 11.1 ppm; MS (ESI) m/z calculated [M+H]+: 
246.2; found [M+H]+: 246.1. 
1-(1-Cyclohexyl-1H-tetrazol-5-yl)-2-methylpropan-1-amine 2,2,2-trifluoroacetate (2i)  
The product was obtained as a light yellow solid (99%). Rf 0.73 (CH2Cl2: MeOH 9:1) 0.73; 
1H NMR (400 MHz, Methanol- d4) δ 4.75 (dd, J =7.6, 2.5, 1H), 4.55 - 4.49 (m, 1H), 2.42 - 2.34 
(m, 1H), 2.09 - 1.94 (m, 6H), 1.80 - 1.78 (m, 1H), 1.61 - 1.50 (m, 2H), 1.44 - 1.36 (m, 1H), 1.11 
(d, J = 6.8, 3H), 0.95 (d, J =6.8, 3H) ppm; 13C NMR (100 MHz, Methanol d4) δ 153.0, 59.3, 
51.0, 34.4, 34.2, 33.5, 26.1, 26.0, 18.5, 18.4 ppm; MS (ESI) m/z calculated [M+H]+: 224.2; 
found [M+H]+: 224.1. 
1-(1-Cyclohexyl-1H-tetrazol-5-yl)-2-phenylethanamine 2,2,2-trifluoroacetate (2j)  
The product was obtained as a light yellow solid (99%). Rf  0.67 (CH2Cl2 : MeOH 9:1) ; 1H 
NMR (400 MHz, Methanol- d4) δ 7.29 - 7.27 (m, 3H), 7.05 - 7.03 (m, 2H), 5.07 (dd, J = 11.2, 
4.8, 1H), 3.74 (m, 1H), 3.51 (dd, J = 12.7, 4.8, 1H), 3.25 - 3.19 (m, 1H), 1.90 - 1.05 (m, 10H) 
ppm; 13C NMR (100 MHz, Methanol d4) δ 153.2, 135.3, 130.6, 130.6, 130.3, 129.1, 59.3, 47.5, 
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Cyclohexyl(1-cyclohexyl-1H-tetrazol-5-yl)methanamine 2,2,2-trifluoroacetate (2k) 
The product was obtained as a white solid (99%). Rf 0.56 (CH2Cl2 : MeOH 9:1); 1H NMR 
(400 MHz, Methanol- d4) δ 4.74 (d, J = 8.2, 1H), 4.52 (m, 1H), 2.08 - 1.85 (m, 8H), 1.81 - 1.70 
(m, 3H), 1.60 - 1.50 (m, 2H), 1.43 - 1.30 (m, 3H), 1.29 - 1.08 (m, 4H) ppm; 13C NMR (100 
MHz, Methanol- d4) δ 152.9, 59.3, 50.1, 42.7, 34.4, 34.3, 29.7, 29.5, 26.6, 26.5, 26.1, 26.0, 25.9 
ppm; MS (ESI) m/z calculated [M+H]+: 264.2; found [M+H]+: 264.1. 
1-(1-cyclohexyl-1H-tetrazol-5-yl)-3-phenylpropan-1-amine 2,2,2-trifluoroacetate (2l)  
The product was obtained as a white solid (99%). Rf  0.67 (CH2Cl2 : MeOH 9:1); 1H NMR 
(400 MHz, Methanol- d4) δ 7.34 - 7.30 (m, 2H), 7.25 - 7.19 (m, 3H), 4.27 - 4.21 (m, 1H), 2.69 
- 2.60 (m, 2H), 2.47 - 2.32 (m, 2H), 2.02 - 1.91 (m, 6H), 1.77 - 1.74 (m, 1H), 1.49 - 1.28 (m, 
4H) ppm; 13C NMR (100 MHz, Methanol- d4) δ 153.1, 140.6, 129.9, 129.3, 129.3, 127.8, 59.4, 
45.3, 36.0, 34.2, 34.0, 31.7, 26.1, 25.9 ppm; MS (ESI) m/z calculated [M+H]+: 286.2; found 
[M+H]+: 286.2. 
Methyl 4-amino-4-(1-phenethyl-1H-tetrazol-5-yl)butanoate 2,2,2-trifluoroacetate (2m)  
The product was obtained as a light yellow solid (99%). Rf 0.51 (CH2Cl2 : MeOH 9:1) ; 1H 
NMR (400 MHz, Methanol- d4) δ 7.25 - 7.15 (m, 3H), 7.11 - 7.09 (m, 2H), 4.78 - 4.62 (m, 2H), 
4.59 - 4.51 (m, 1H), 3.27 (dd, J = 8.5, 5.3, 2H), 2.27 - 2.15 (m, 2H), 1.99 - 1.79 (m, 1H) ppm; 
13C (100 MHz, Methanol- d4) δ 174.1, 138.2, 130.0, 129.9, 128.3, 52.4, 50.2, 45.0, 36.6, 29.6, 
29.2 ppm; MS (ESI) m/z calculated [M+H]+: 290.2; found [M+H]+: 290.3. 
Ethyl 2-(amino(1-phenethyl-1H-tetrazol-5-yl)methyl)cyclopropanecarboxylate 2,2,2-
trifluoroacetate (2n)  
The product was obtained as a mixture of diastereomers as a colorless oil (99%). Rf  0.44 
(CH2Cl2 : MeOH 9:1); 1H NMR (400 MHz, Methanol- d4) δ 7.31 - 7.24 (m, 3H), 7.19 - 7.13 
(m, 2H), 4.72 - 4.66 (m, 3H), 4.18 - 4.05 (m, 3H), 3.34 - 3.28 (m, 3H), 1.99 - 1.87 (m, 1H), 1.86 
- 1.62 (m, 1H), 1.25 -1.02 (m, 4H), 0.95 - 0.75 (m, 1H) ppm; 13C (100 MHz, Methanol- d4) δ 
173.7, 154.2, 138.2, 130.1, 130.0, 128.5, 62.4, 50.4, 36.7, 24.5, 20.4, 19.6, 14.6, 13.7 ppm; MS 
(ESI) m/z calculated [M+H]+: 316.2; found [M+H]+: 316.2. 
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Ethyl 2-(amino(1-(tert-butyl)-1H-tetrazol-5-yl)methyl)cyclopropanecarboxylate (2o)  
The product was obtained as a light yellow oil (98%). Rf 0.47 (CH2Cl2 : MeOH 9:1); 1H NMR 
(400 MHz, Methanol- d4) δ 4.10 - 4.02 (m, 2H), 3.57 - 3.52 (m, 2H), 2.12 (dt, J = 8.7, 6.4, 1H), 
1.94 - 1.92 (m, 1H), 1.72 (s, 9H), 1.28 - 1.22 (m, 2H), 1.21 - 1.18 (m, 3H), 1.17 - 1.14 (m, 3H), 
1.13 - 1.10 (m, 2H) ppm; 13C (100 MHz, Methanol- d4) δ 172.2, 150.6, 62.9, 62.9, 60.9, 29.0, 
23.0, 19.0, 17.4, 13.0 ppm; MS (ESI) m/z calculated [M+H]+: 268.2;found [M+H]+: 268.2. 
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(1-Phenethyl-1H-tetrazol-5-yl)methanamine 2,2,2-trifluoroacetate (2a) 
 
 
1-(1-Phenethyl-1H-tetrazol-5-yl)ethanamine 2,2,2-trifluoroacetate (2b) 
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1-(1-Benzyl-1H-tetrazol-5-yl)-3-methylbutan-1-amine 2,2,2-trifluoroacetate (2e) 
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(1-Benzyl-1H-tetrazol-5-yl)(cyclopropyl)methanamine 2,2,2-trifluoroacetate (2f) 
 
 
1-(1-Cyclohexyl-1H-tetrazol-5-yl)ethanamine 2,2,2-trifluoroacetate (2g) 
 
 
1-(1-Benzyl-1H-tetrazol-5-yl)-2-methylbutan-1-amine 2,2,2-trifluoroacetate (2h) 
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1-(1-Cyclohexyl-1H-tetrazol-5-yl)-2-methylpropan-1-amine 2,2,2-trifluoroacetate (2i) 
 
 
1-(1-Cyclohexyl-1H-tetrazol-5-yl)-2-phenylethanamine 2,2,2-trifluoroacetate (2j) 
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1-(1-Cyclohexyl-1H-tetrazol-5-yl)-3-phenylpropan-1-amine 2,2,2-trifluoroacetate (2l) 
 
 
Methyl 4-amino-4-(1-phenethyl-1H-tetrazol-5-yl)butanoate 2,2,2-trifluoroacetate (2m) 
 
 
Ethyl 2-(amino(1-phenethyl-1H-tetrazol-5-yl)methyl)cyclopropanecarboxylate (2n) 
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Ethyl 2-(amino(1-(tert-butyl)-1H-tetrazol-5-yl)methyl) cyclopropanecarboxylate (2o) 
 
4.4.5 Single crystal X-ray structure determination of compounds 1b, 1c, 2k and 2l 
4.4.5.1 General 
The data was collected on a X-ray single crystal diffractometer equipped with a CCD detector 
(Bruker, APEX II, κ-CCD), a rotating anode (Bruker AXS, FR591) with MoKα radiation (λ = 
0.71073 Å), and a graphite monochromator by using the SMART software package.27 The 
measurements were performed on single crystals coated with perfluorinated ether. The crystals 
were fixed on the top of a glass fiber, transferred to the diffractometer and frozen under a stream 
of cold nitrogen. A matrix scan, using three short runs, was used to determine the initial lattice 
parameters. Reflections were merged and corrected for Lorenz and polarization effects, scan 
speed, and background using SAINT.28 Absorption corrections, including odd and even ordered 
spherical harmonics were performed using SADABS.28 Space group assignments were based 
upon systematic absences, E statistics, and successful refinement of the structures. Structures 
were solved by direct methods with the aid of successive difference Fourier maps, and were 
refined against all data using WinGX29 based on SIR-92.30 Hydrogen atoms could be located in 
the difference Fourier maps and were allowed to refine freely. If not mentioned otherwise, non-
hydrogen atoms were refined with anisotropic displacement parameters. Full-matrix least-
squares refinements were carried out by minimizing Σw(Fo2-Fc2)2 with SHELXL-9731 
weighting scheme. Neutral atom scattering factors for all atoms and anomalous dispersion 
corrections for the non-hydrogen atoms were taken from International Tables for 
Crystallography.32 Images of the crystal structures were generated by PLATON.33 CCDC 
903083 (2) and 903084 (3) contains the supplementary crystallographic data for this paper. 
These data can be obtained free of charge from The Cambridge Crystallographic Data Centre 
via www.ccdc.cam.ac.uk/data_request/cif.  
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4.4.5.2 Single Crystal X-ray Structure Determination of Compound 1b 
 
 
Figure 4.3. – Ortep drawing of compound 1b with 50% ellipsoids.33 The asymmetric unit 
contains two crystallographical independent molecules A (right) and B (left). 
Operator:         *** Herdtweck *** 
Molecular Formula: C30 H29 N5 
Crystal Color / Shape Colorless fragment 
Crystal Size Approximate size of crystal fragment used for data 
collection: 0.38  0.41  0.51 mm 
Molecular Weight: 459.58 a.m.u. 
F000:  1952 
Systematic Absences: h0l: h+l≠2n; 0k0: k≠2n 
Space Group: Monoclinic P 21/n (I.T.-No.: 14) 
Cell Constants: Least-squares refinement of 9965 reflections with the 
programs "APEX suite" and "SAINT"27, 28; theta range 1.49° 
<  < 25.39°; Mo(K ); λ = 71.073 pm 
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 a = 1287.10(3) pm 
 b = 2236.50(4) pm β = 95.9558(10)° 
 c = 1735.26(4) pm 
 V = 4968.16(19)· 106 pm3; Z = 8; Dcalc = 1.229 g cm-3; Mos. 
= 0.65 
Diffractometer: Kappa APEX II (Area Diffraction System; BRUKER AXS); 
sealed tube; graphite monochromator; 50 kV; 30 mA; λ = 
71.073 pm; Mo(K ) 
Temperature: (-150±1) °C; (123±1) K 
Measurement Range: 1.49° <  < 25.39°; h: -15/15,  k: -26/26, l: -20/20 
Measurement Time: 2  7.50 s per film 
Measurement Mode: measured: 11 runs; 6287 films / scaled: 11 runs; 6287 films 
 Φ- and ω- movement; Increment: Δφ/Δω = 0.50°; dx = 50.0 
mm 
LP - Correction: Yes28 
Intensity Correction No/Yes; during scaling28 
Absorption Correction: Multi-scan; during scaling; µ = 0.074 mm-1 28 
 Correction Factors: Tmin = 0.6999 Tmax = 0.7452 
Reflection Data: 187914 reflections were integrated and scaled 
 3575 reflections systematic absent and rejected  
 184339 reflections to be merged 
 9131 independent reflections 
 0.023 Rint: (basis Fo2) 
 9131 independent reflections (all) were used in 
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  refinements 
 8192 independent reflections with Io > 2σ (Io) 
 99.9 % completeness of the data set 
 864 parameter full-matrix refinement 
 10.6 reflections per parameter 
Solution: Direct Methods;29, 30 Difference Fourier syntheses 
Refinement Parameters: In the asymmetric unit: 
 70 Non-hydrogen atoms with anisotropic 
  displacement parameters 
 58 Hydrogen atoms with isotropic displacement  
  parameters 
Hydrogen Atoms: All hydrogen atom positions were found in the difference 
map calculated from the model containing all non-hydrogen 
atoms. The hydrogen positions were refined with individual 
isotropic displacement parameters. 
Atomic Form Factors: For neutral atoms and anomalous dispersion29, 30, 32 
Extinction Correction:  Fc (korr) = kFc[1+ 0.001· ε· Fc2λ　3/sin(2ϴ)]-1/4  SHELXL-
97 [5, 7], εrefined to ε= 0.0013(2) 
Weighting Scheme: w-1 = σ2(Fo2)+(a*P)2+b*P 
 with a: 0.0338; b: 1.6444; P: [Maximum(0 or Fo2)+2*Fc2]/3 
Shift/Err: Less than 0.001 in the last cycle of refinement: 
Resid. Electron Density: +0.26 e0;- /Å3; -0.18 e0;- /Å3 
R1: Σ (||Fo|-|Fc||)/Σ|Fo| 
[Fo > 4σ (Fo); N=8192]:  =0.0309 
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[all reflctns; N=9131]:  = 0.0355 
wR2: [Σw(Fo2-Fc2)2/Σw(Fo2)2]1/2 
[Fo > 4σ (Fo); N=8192]:  =0.0746 
[all reflctns; N=9131]:  =0.0782 
Goodness of fit: [Σw(Fo2-Fc2)2/(NO-NV)]1/2 =1.017 
Remarks: Refinement expression   Σw(Fo2-Fc2)2 
4.4.5.3 Single Crystal X-ray Structure Determination of Compound 1c 
 
Figure 4.4. Ortep drawing of compound 1c with 50% ellipsoids.31 The asymmetric unit 
contains two crystallographical independent molecules A (left) and B (right). 
Operator:   *** Herdtweck *** 
Molecular Formula: C32 H33 N5 
Crystal Color / Shape Colorless column 
Crystal Size Approximate size of crystal fragment used for data 
collection: 0.13  0.18  0.56 mm 
Chapter 4 
Page | 216 
Molecular Weight: 487.63 a.m.u. 
F000:  2080 
Systematic Absences: h0l: h+l≠2n; 0k0: k≠2n 
Space Group: Monoclinic P 21/n (I.T.-No.: 14) 
Cell Constants: Least-squares refinement of 9826 reflections with the 
programs "APEX suite" and "SAINT";27, 28 theta range 1.27° 
<  < 25.40°; Mo(K ); λ = 71.073 pm 
 a = 1883.72(3) pm 
 b = 1470.33(2) pm β = 109.2152(8)° 
 c = 2051.41(3) pm 
 V = 5365.23(14)· 106 pm3; Z = 8; Dcalc = 1.207 g cm-3; Mos. 
= 0.64 
Diffractometer: Kappa APEX II (Area Diffraction System; BRUKER AXS); 
sealed tube; graphite monochromator; 50 kV; 30 mA; λ = 
71.073 pm; Mo(K ) 
Temperature: (-150±1) °C; (123±1) K 
Measurement Range: 1.27° <  < 25.40°;  h: -22/22,  k: -17/17,  l:  -24/24 
Measurement Time: 2  10 s per film 
Measurement Mode: measured: 9 runs; 3537 films / scaled: 9 runs; 3537 films 
 Φ- and ω- movement; Increment: Δφ/Δω = 0.50°; dx = 55.0 
mm 
LP - Correction: Yes28 
Intensity Correction No/Yes; during scaling28 
Absorption Correction: Multi-scan; during scaling; µ = 0.073 mm-1 28 
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 Correction Factors:  Tmin = 0.6883 Tmax =0.7452 
Reflection Data: 102777 reflections were integrated and scaled 
 3088 reflections systematic absent and rejected  
 99689 reflections to be merged 
 9881 independent reflections 
 0.036 Rint: (basis Fo2) 
 9881 independent reflections (all) were used in 
refinements 
 8145 independent reflections with Io > 2σ (Io) 
 100 % completeness of the data set 
 931 parameter full-matrix refinement 
 10.6 reflections per parameter 
Solution: Direct Methods;29, 30 Difference Fourier syntheses 
Refinement Parameters: In the asymmetric unit: 
 74 Non-hydrogen atoms with anisotropic 
  displacement parameters 
 66 Hydrogen atoms with isotropic 
  displacement 
  parameters 
Hydrogen Atoms: All hydrogen atom positions were found in the difference 
map calculated from the model containing all non-hydrogen 
atoms. The hydrogen positions were refined with individual 
isotropic displacement parameters. 
Atomic Form Factors: For neutral atoms and anomalous dispersion29, 31, 32 
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Extinction Correction:  no 
Weighting Scheme: w-1 = σ2(Fo2)+(a*P)2+b*P 
 with a: 0.0352; b: 1.7749; P: [Maximum(0 or Fo2)+2*Fc2]/3 
Shift/Err: Less than 0.001 in the last cycle of refinement: 
Resid. Electron Density: +0.23 e0;- /Å3; -0.18 e0;- /Å3 
R1: Σ (||Fo|-|Fc||)/Σ|Fo| 
[Fo > 4σ(Fo); N=8145]:  = 0.0335 
[all reflctns; N=9881]:  = 0.0454 
wR2: [Σw(Fo2-Fc2)2/Σw(Fo2)2]1/2 
[Fo > 4σ (Fo); N=8145]:  = 0.0759 
[all reflctns; N=9881]:  = 0.0824 
Goodness of fit: [Σw(Fo2-Fc2)2/(NO-NV)]1/2 = 1.019 
Remarks: Refinement expression   Σw(Fo2-Fc2)2 
4.4.5.4 Single Crystal X-ray Structure Determination of Compound 2k 
Operator: *** Herdtweck *** 
Molecular Formula: C16 H26 F3 N5 O2 
 [(C14 H26 N5)+], [(C2 F3 O2)-] 
Crystal Color / Shape Colorless needle 
Crystal Size Approximate size of crystal fragment used for data 
collection: 0.03  0.10  0.51  mm 
Molecular Weight: 377.42 a.m.u. 
F000:  800 
Systematic Absences: h0l: h+l≠2n;  0k0: k≠2n 
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Space Group: Monoclinic P 21/n (I.T.-No.: 14) 
Cell Constants: Least-squares refinement of 9930 reflections with the 
programs "APEX suite" and "SAINT"; theta range 1.66° <  
< 25.33°; Mo(K ); λ = 71.073 pm 
 a = 1439.81(8) pm 
 b = 637.02(4) pm β = 95.573(3)° 
 c = 2046.67(12) pm 
 V = 1868.31(19)· 106 pm3; Z = 4; Dcalc = 1.342 g cm-3; Mos. 
= 0.69 
Diffractometer: Kappa APEX II (Area Diffraction System; BRUKER AXS); 
rotating anode; graphite monochromator; 50 kV; 40 mA; λ = 
71.073 pm; Mo(K ) 
Temperature: (-150±1) °C; (123±1) K 
Measurement Range: 1.66° <  < 25.33°;  h: -17/17,  k: -7/7,  l:  -24/24 
Measurement Time: 2  15 s per film 
Measurement Mode: measured: 7 runs; 4008 films / scaled: 7 runs; 4008 films 
 Φ- and ω- movement; Increment: Δφ/Δω = 0.50°; dx = 45.0 
mm 
LP - Correction: Yes 
Intensity Correction No/Yes; during scaling 
Absorption Correction: Multi-scan; during scaling; µ = 0.111 mm-1  
 Correction Factors: Tmin = 0.7004 Tmax = 0.7452 
Reflection Data: 50096 reflections were integrated and scaled 
 3323 reflections systematic absent and rejected  
 46773 reflections to be merged 
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 3411 independent reflections 
 0.032 Rint: (basis Fo2) 
 3411 independent reflections (all) were used in 
  refinements 
 2990 independent reflections with Io > 2σ(Io) 
 99.9 % completeness of the data set 
 339 parameter full-matrix refinement 
 10.1 reflections per parameter 
Solution: Direct Methods; Difference Fourier syntheses 
Refinement Parameters: In the asymmetric unit: 
 26 Non-hydrogen atoms with anisotropic 
  displacement parameters 
 26 Hydrogen atoms with isotropic 
  displacement parameters 
Hydrogen Atoms: All hydrogen atom positions were found in the difference 
map calculated from the model containing all non-hydrogen 
atoms. The hydrogen positions were refined with individual 
isotropic displacement parameters. 
Atomic Form Factors: For neutral atoms and anomalous dispersion 
Extinction Correction:  no 
Weighting Scheme: w-1 = σ2(Fo2)+(a*P)2+b*P 
 with a: 0.0411; b: 1.3698; P: [Maximum(0 or Fo2)+2*Fc2]/3 
Shift/Err: Less than 0.001 in the last cycle of refinement: 
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Resid. Electron Density: +0.51 e0;- /Å3; -0.37 e0;- /Å3 
R1: Σ(||Fo|-|Fc||)/Σ|Fo| 
[Fo > 4σ(Fo); N=2990]:  = 0.0367 
[all reflctns; N=3411]:  = 0.0428 
wR2: [Σw(Fo2-Fc2)2/Σw(Fo2)2]1/2 
[Fo > 4σ(Fo); N=2990]:  = 0.0913 
[all reflctns; N=3411]:  = 0.0966 
Goodness of fit: [Σw(Fo2-Fc2)2/(NO-NV)]1/2 = 1.026 
Remarks: Refinement expression   Σw(Fo2-Fc2)2 
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4.4.5.5 Single Crystal X-ray Structure Determination of Compound 2l 
 
Figure 4.6. Ortep drawing of compound 2l with 50% ellipsoids. The asymmetric unit 
contains two crystallographical independent molecules A (right) and B (left). 
Operator: *** Herdtweck *** 
Molecular Formula: C18 H24 F3 N5 O2 
 [(C16 H24 N5)+], [(C2 F3 O2)-] 
Crystal Color / Shape Colorless needle 
Crystal Size Approximate size of crystal fragment used for data collection: 0.05 
 0.13  0.76 mm 
Molecular Weight: 399.42 a.m.u. 
F000:  1680 
Systematic Absences: hkl: h+k≠2n; h0l: l≠2n 
Space Group: Monoclinic C c (I.T.-No.: 9) 
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Cell Constants: Least-squares refinement of 9984 reflections with the programs 
"APEX suite" and "SAINT" [1,2]; theta range 1.29° <  < 25.42°; 
Mo(K ); λ = 71.073 pm 
 a = 3158.00(13) pm 
 b = 595.17(2) pm β = 92.442(2)° 
 c = 2090.57(9) pm 
 V = 3925.8(3)· 106 pm3; Z = 8; Dcalc = 1.352 g cm-3; Mos. = 0.65 
Diffractometer: Kappa APEX II (Area Diffraction System; BRUKER AXS); rotating 
anode; graphite monochromator; 50 kV; 40 mA; λ = 71.073 pm; 
Mo(K ) 
Temperature: (-150±1) °C; (123±1) K 
Measurement Range: 1.29° <  < 25.42°; h: -38/38,  k: -7/7,  l:  -25/25 
Measurement Time: 2  10 s per film 
Measurement Mode: measured: 7 runs; 3959 films / scaled: 7 runs; 3959 films 
 Φ- and ω- movement; Increment: Δφ/Δω = 0.50°; dx = 55.0 mm 
LP - Correction: Yes 
Intensity Correction No/Yes; during scaling 
Absorption Correction: Multi-scan; during scaling; µ = 0.110 mm-1 
 Correction Factors: Tmin = 0.5889 Tmax = 0.7452 
Reflection Data: 40550 reflections were integrated and scaled 
 2405 reflections systematic absent and rejected  
 38145 reflections to be merged 
 7198 independent reflections 
 0.043 Rint: (basis Fo2) 
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 7198 independent reflections (all) were used in 
  refinements 
 6976 independent reflections with Io > 2σ(Io) 
 99.5 % completeness of the data set 
 697 parameter full-matrix refinement 
 10.3 reflections per parameter 
Solution: Direct Methods; Difference Fourier syntheses 
Refinement Parameters: In the asymmetric unit: 
 56 Non-hydrogen atoms with anisotropic 
  displacement parameters 
 48 Hydrogen atoms with isotropic displacement 
  parameters 
Hydrogen Atoms: All hydrogen atom positions were found in the difference map 
calculated from the model containing all non-hydrogen atoms. The 
hydrogen positions were refined with individual isotropic 
displacement parameters. 
Atomic Form Factors: For neutral atoms and anomalous dispersion 
Extinction Correction:  no 
Weighting Scheme: w-1 = σ2(Fo2)+(a*P)2+b*P 
 with a: 0.0397; b: 2.1277; P: [Maximum(0 or Fo2)+2*Fc2]/3 
Shift/Err: Less than 0.001 in the last cycle of refinement: 
Resid. Electron Density: +0.20 e0;- /Å3; -0.20 e0;- /Å3 
R1: Σ(||Fo|-|Fc||)/Σ|Fo| 
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[Fo > 4σ(Fo); N=6976]:  = 0.0305 
[all reflctns; N=7198]:  = 0.0316 
wR2: [Σw(Fo2-Fc2)2/Σw(Fo2)2]1/2 
[Fo > 4σ(Fo); N=6976]:  = 0.0781 
[all reflctns; N=7198]:  = 0.0791 
Goodness of fit: [Σw(Fo2-Fc2)2/(NO-NV)]1/2 = 1.025 
Flack's Parameter: x = 0.4(4) 
Remarks: Refinement expression   Σw(Fo2-Fc2)2 
 The correct enantiomere could not be proved by Flack's Parameter. 
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